Stereotaxis, Inc. (STXS) Executive Compensation
Stereotaxis, Inc. (STXS) is a publicly traded company on the NYSE, categorized under SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: STXS
CIK: 1289340
Exchange: NYSE
SIC 3845: Electromedical & Electrotherapeutic Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerTimothy Fagan
Audit LocationSaint Louis, Missouri, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-19 | — | SCHEDULE 13G Filing | 0001099910-26-000250 | View SEC Doc Filr Page |
| EFFECT | 2026-08-13 | — | EFFECT Filing | 9999999995-26-002657 | View SEC Doc Filr Page |
| EFFECT | 2026-08-13 | — | EFFECT Filing | 9999999995-26-002656 | View SEC Doc Filr Page |
| 424B3 | 2026-08-13 | — | 424B3 | 0001493152-26-037775 | View SEC Doc Filr Page |
| 424B3 | 2026-08-13 | — | 424B3 | 0001493152-26-037771 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001493152-26-037357 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001493152-26-037113 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-15 | 8-K | 0001493152-26-033405 | View SEC Doc Filr Page |
| S-3 | 2026-07-15 | — | S-3 | 0001493152-26-033398 | View SEC Doc Filr Page |
| S-3 | 2026-07-15 | — | S-3 | 0001493152-26-033396 | View SEC Doc Filr Page |
| 8-K | 2026-07-09 | 2026-07-07 | 8-K | 0001493152-26-032598 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031537 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031536 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031535 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031533 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031534 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-07-01 | 4 | 0001493152-26-031531 | View SEC Doc Filr Page |
| SD | 2026-05-29 | — | SD | 0001493152-26-026337 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001493152-26-023735 | View SEC Doc Filr Page |
| 8-K | 2026-05-15 | 2026-05-14 | 8-K | 0001493152-26-023654 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001493152-26-022697 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001493152-26-022488 | View SEC Doc Filr Page |
| 8-K | 2026-04-15 | 2026-04-14 | 8-K | 0001493152-26-016685 | View SEC Doc Filr Page |
| 4 | 2026-04-13 | 2026-04-11 | 4 | 0001493152-26-016398 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-03 | 2025-12-31 | 10-K/A | 0001493152-26-015172 | View SEC Doc Filr Page |